Article
Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Journal of autoimmunity - 1 Aug 2018
Kim Yong Chan, Zhang Ai-Hong, Yoon Jeongheon, Culp William E, Lees Jason R, Wucherpfennig Kai W, Scott David W
Abstract excerpt
Expanded polyclonal T regulatory cells (Tregs) offer great promise for the treatment of immune-mediated diseases. Inhibition by Tregs is under the control of the T-cell receptor (TCR). Therefore, we created Tregs with defined antigen specificity, using a recombinant T-cell receptor isolated from a myelin-basic protein specific T-cell clone of a multiple sclerosis (MS) patient (Ob2F3). We expressed this TCR using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
